Development and Test of a Communication Skills Training for Transplant Providers - Aims 2 & 3

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorTemple University

About this trial

The goal of this clinical trial is to understand the communication occurring between Black and Caucasian patients and their transplant providers during transplant evaluation consultations and assess relationships between these communicative elements and patient and provider factors, patient-reported outcomes and living donor transplant outcomes - living donor referrals, evaluations, and transplants. We will use these findings to inform the development of a communication skills training for transplant providers and test the impact of the training on providers' communication about live donor kidney transplants with Black and Caucasian patients and living donor transplant outcomes.

The main questions it aims to answer are:

* How does the use of the use of instrumental, relational and affective communication by patients and providers during the transplant consultation differ by patient and provider factors, patient-reported outcomes and patient ethnicity? * What elements of instrumental, relational and affective communication will be predictive of live donor kidney transplant (LDKT) process outcomes (LD inquiries and evaluations, and actual LDKTs)?

Participants will be asked to complete brief surveys before and after the transplant consultation and to give permission for the consultation to be audiorecorded.

This data will be used to develop a training to educate providers on the key communication factors predictive of LDKT process outcomes specific to Black and Caucasian patients, and provide guidance on their application during patient consultations. Researchers will then compare communication and patient-reported and LDKT process outcomes between trained and untrained providers to see whether the training has any effect on living donor inquiries and evaluations, and actual LDKTs.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

(1) appear for a kidney transplant evaluation at Cooperman Barnabas Medical Center (CBMC) or Temple University Hospital (TUH)

(2) speak English

(3) be of self-reported Black or Caucasian ethnicity

(4) be ≥18 years of age.

Disqualifiers

(1) are non-verbal or otherwise unable to converse with providers

(2) are already listed for kidney transplant at CBMC or TUHS or at another transplant center

(3) have limited English proficiency and speak directly with the physician in a language other than English.

Trial design

Design model

Single group

Treatments tested in this trial

  • EPPComm Provider Training

    Behavioral

    A curriculum will be developed to educate patients about LDKT and promote the search of potential living donors while supporting patients' values and cultural preferences. The curriculum will consist of two components: didactic education and skills-based communication. The didactic component provides evidence of the impact of patient-provider communication and LDKT process outcomes for Black and Caucasian patients. The skills-based component will build communication confidence leading discussions about LDKT. It provides instructions for the key communication skills needed to confidently assuage patients' concerns about LDKT/live donation and motivates patients to search for living donor. The following will be covered: providing LDKT information/answering questions, highlighting LDKT benefits, refuting live donation misinformation, and encouraging patients to seek living donors.

Treatment groups

70 Participants
are divided into 1 treatment group
Group A: EPPCom Provider TrainingExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Live donor inquiries

Whether potential donors return a completed donor referral form to the patient's transplant program (yes/no)

Time frame
Through study completion, 4 years
2

Live donor evaluations

Whether potential donor appears, in-person, for the donor evaluation (yes/no)

Time frame
Through study completion, 4 years
3

Live donor kidney transplant

Whether patient receives a live donor kidney transplant (yes/no)

Time frame
Through study completion, 4 years

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Temple University

Lead sponsor

Cooperman Barnabas Medical Center

Collaborator

This trial is not recruiting at the moment. You can still explore other options: